In conclusion, the assessment of myeloid cell densities within their spatial context seems to be essential for identifying immune microenvironment differences between hrHPV− and hrHPV+ PSCC, with the latter having higher CD14+, CD68+ and CD163+ myeloid cell infiltration in the intratumoral tumor (IT Tumor) compartment. The gene discussed is CD14; the disease is neoplasm.